Synopsis- The provisional approval is for two doses of the paediatric Pfizer COVID-19 vaccine, given at least 21 days apart, the health…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Virus
-
-
CompaniesPfizerPharma Science & Research
Swissmedic Approves Pfizer/ BioNTech Vaccine for Children Over 5
by adminby adminSummary: The clinical trial results show that the vaccine is safe and effective in this in this age group, it will thus…
-
AstraZenecaPharma Science & Research
France HAS Approves AstraZeneca’s Evusheld for High-Risk Covid Cases
by adminby adminSummary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
-
Synopsis- Alembic said it has acquired preferred stock in RIGImmune amounting to a 19.97% post-money stake in the first closing of the…
-
AstraZenecaCovid DrugsRegulatoryU.S FDA
FDA Approves AstraZeneca’s Evusheld becomes First Authorized COVID Antibody to Protect the Immunocompromised Before Exposure
by adminby adminSummary : With the FDA’s emergency use authorization today of AstraZeneca’s long-acting antibody cocktail, the roughly 2% of U.S. residents who are…
-
AstraZenecaIndia
AstraZeneca is in Contact with Indian Authorities to have Evusheld Approved.
by adminby adminSummary : The company also said studies are underway to provide information on the impact of the new Omicron variant on Evusheld,…
-
CompaniesPfizer
Booster dose of Pfizer-BioNTech vaccine Necessitate for Shielding Against Omicron
by adminby adminSummary – Pfizer says the protection provided by two doses of its anti-COVID-19 vaccine against previous strains will match that provided by…
-
Summary : The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that…
-
IndiaPharma Science & Research
The NTAGI is Considering Giving Immunocompromised Persons a “Additional” Dosage of COVID-19 Vaccination.
by adminby adminSynopsis: A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is…
-
Synopsis: The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12 The therapy, Bamlanivimab plus…